Susanne Schaffert

Insider Reports History

Entity
Individual
Location
C/O Rubius Therapeutics, Inc., 399 Binney Street, Suite 300, Cambridge, MA
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susanne Schaffert:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INCYTE CORP Director Common Stock 5.72K $343K $59.94 Jun 12, 2024 Direct
Rubius Therapeutics, Inc. Director Stock Option (Right to Buy) 50K Jul 29, 2022 Direct
INCYTE CORP Director Non Qualfied Stock Option (right to buy) 12.5K Jun 12, 2024 Direct
INCYTE CORP Director Non-Qualified Stock Option (right to buy) 11.3K Jun 14, 2023 Direct

Insider Reports Filed by Susanne Schaffert

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INCY INCYTE CORP Jun 12, 2024 3 -$45.1K 4 Jun 14, 2024 Director
INCY INCYTE CORP Jun 14, 2023 3 -$30K 4 Jun 16, 2023 Director
INCY INCYTE CORP Oct 3, 2022 2 $0 4 Oct 5, 2022 Director
INCY INCYTE CORP Oct 1, 2022 0 $0 3 Oct 5, 2022 Director
RUBY Rubius Therapeutics, Inc. Jul 29, 2022 1 $0 4 Aug 1, 2022 Director
RUBY Rubius Therapeutics, Inc. Jul 12, 2022 0 $0 3 Jul 19, 2022 Director